MedPath

Effect of Myrtus Communis L. (Myrtle) syrup in patients with chronic rhinosinusitis

Phase 2
Conditions
chronic rhinosinusitis.
Other chronic sinusitis (chronic) involving more than one sinus but not pansinusitis
Registration Number
IRCT2016020926465N1
Lead Sponsor
Vice Chancellor for research, Shahid Sadoughei University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients with chronic rhinosinusitis; over 18 years old; who come to the Masih Daneshvari hospital; Patients who suffer from rhinosinusitis symptoms for more than three months; Patients with chronic rhinosinusitis according to lund McKay scale criteria approved by an expert; Patients who would like to participate in voluntary and completed informed consent; Do not have sinus surgery; No sensitivity to common antibiotics or herbal remedies; Not pregnant or Plan to become pregnant; No immune deficiency (AIDS, diabetes or transplant); No acute respiratory disease in 7 days; Not have complicated acute sinusitis like an abscess; Not have acute symptoms such as severe pain or pressure, fever and purulent discharge; No ocular or brain complication of Sinusitis; No previous use of antibiotics in 7 days; Not use systemic corticosteroids in the last three months; Not any mental or psychological problem that cannot collaborate in projects.
Exclusion criteria: Any type of serious complication or sensitivity to prescription drugs in this study; Pregnancy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SNOT-22. Timepoint: before/after (after1 month). Method of measurement: fill questionnaire.
Secondary Outcome Measures
NameTimeMethod
VAS )visual analog scale). Timepoint: before, after(after 1 month). Method of measurement: Self-assessment questionnaire.
© Copyright 2025. All Rights Reserved by MedPath